Form 3 Filing by ORAMED PHARMACEUTICALS INC. for Lifeward Ltd.

This filing details ORAMED PHARMACEUTICALS INC.'s beneficial ownership of Lifeward Ltd. (LFWD) shares. ORAMED PHARMACEUTICALS INC. holds 1,250,363 ordinary shares directly. The filing also outlines various warrants and convertible notes that allow for the acquisition of additional ordinary shares, subject to beneficial ownership limitations. Specifically, pre-funded warrants and share purchase warrants are subject to a 49.99% ownership limitation, while purchase agreement warrants and senior secured convertible notes are subject to a 45.0% ownership limitation. The exercise and conversion of these instruments are restricted to prevent ORAMED PHARMACEUTICALS INC. from exceeding these thresholds. The footnotes clarify the conditions under which these limitations apply and the free exercisability or convertibility of the instruments, subject to these restrictions.